{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-098281","form_type":"8-K","ticker":"BJDX","cik":"0001704287","company_name":"Bluejay Diagnostics, Inc.","filed_at":"2025-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.204219+00:00","generated_at":"2026-05-17T03:54:55.878957+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bluejay Diagnostics raises $4.5M in private placement of stock and warrants","bullets":["Gross proceeds of $4.5M; net proceeds ~$4.0M after 8% placement agent fee and expenses.","Issued 2.25M shares/pre-funded warrants at $2.00/unit plus Series F warrants for 4.5M shares at $1.75.","Net proceeds to fund FDA approval efforts, clinical studies, R&D, and working capital.","Rodman & Renshaw acted as exclusive placement agent; warrants include 4.99%/9.99% beneficial ownership caps.","Company agreed to file resale registration statement by Oct 24, 2025, and has 90-day issuance lock-up post-effectiveness."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-098281","json":"https://secwatch.observer/filing/0001213900-25-098281.json","markdown":"https://secwatch.observer/filing/0001213900-25-098281.md","text":"https://secwatch.observer/filing/0001213900-25-098281.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/0001213900-25-098281-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/ea0260965-8k_bluejay.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:54:55.878957+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05eafb79ce82eb1ab539bc43505f4bab7110e906","claim":"Bluejay Diagnostics, Inc. issued 175,000 shares of common stock to institutional, accredited investors for $2.00 per share.","evidence_excerpt":"and (ii) Series F warrants (“Series F Warrants”) to purchase up to 4,500,000 shares of common stock. The combined price of securities sold in the private placement was $2.00 per share of common stock (or pre-funded warrant in lieu thereof, in which case such price was reduced by $0.0001) and accompanying Series F Warrants to acquire two shares of","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/0001213900-25-098281-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"175,000 shares"},{"label":"Purchaser","value":"institutional, accredited investors"},{"label":"Consideration","value":"$2.00 per share"}],"fact_type":"equity_issuance"},{"claim_id":"1bdfb97f61f0e448d53a4c85594de37ea92c8383","claim":"Bluejay Diagnostics, Inc. issued Placement Agent Warrants to purchase up to an aggregate of 180,000 shares of common stock of warrant to Rodman and Renshaw LLC (placement agent) for 125% of the combined price per share.","evidence_excerpt":"the “common warrants”) to purchase up to an aggregate of 180,000 shares of common stock on the same terms as the Series F Warrants, except that the exercise price per share is 125% of the combined price per share and Series F Warrants sold in the offering. Pursuant to the terms of the registration rights agreement, the Company has agreed to register for","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/0001213900-25-098281-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"Placement Agent Warrants to purchase up to an aggregate of 180,000 shares of common stock"},{"label":"Purchaser","value":"Rodman and Renshaw LLC (placement agent)"},{"label":"Consideration","value":"125% of the combined price per share"}],"fact_type":"equity_issuance"},{"claim_id":"86d69392668b8c7335d283fd52b98ece05de7d67","claim":"Bluejay Diagnostics, Inc. issued Series F Warrants to purchase up to 4,500,000 shares of common stock of warrant to institutional, accredited investors for $2.00 per share.","evidence_excerpt":"and (ii) Series F warrants (“Series F Warrants”) to purchase up to 4,500,000 shares of common stock. The combined price of securities sold in the private placement was $2.00 per share of common stock (or pre-funded warrant in lieu thereof, in which case such price was reduced by $0.0001) and accompanying Series F Warrants to acquire two shares of","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/0001213900-25-098281-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"Series F Warrants to purchase up to 4,500,000 shares of common stock"},{"label":"Purchaser","value":"institutional, accredited investors"},{"label":"Consideration","value":"$2.00 per share"}],"fact_type":"equity_issuance"},{"claim_id":"d12a30ac1056486e764495a97ae152cb9e34f448","claim":"Bluejay Diagnostics, Inc. issued Pre-Funded Warrants to purchase up to 2,075,000 shares of common stock of warrant to institutional, accredited investors for $2.00 per share.","evidence_excerpt":"and (ii) Series F warrants (“Series F Warrants”) to purchase up to 4,500,000 shares of common stock. The combined price of securities sold in the private placement was $2.00 per share of common stock (or pre-funded warrant in lieu thereof, in which case such price was reduced by $0.0001) and accompanying Series F Warrants to acquire two shares of","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025098281/0001213900-25-098281-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"Pre-Funded Warrants to purchase up to 2,075,000 shares of common stock"},{"label":"Purchaser","value":"institutional, accredited investors"},{"label":"Consideration","value":"$2.00 per share"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}